Senior insider sale
TG THERAPEUTICS, INC. — senior position signals high conviction
$672.2K
20.85K shares
What this filing means
LONIAL SAGAR plans to sell 20.85K shares of TG THERAPEUTICS, INC. valued at approximately $672.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2025ACC: 0001959173-25-005946
20.85K
Shares to sell
$672.2K
Approx. market value
20.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/22/2023
20.85KTotal acquired20.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/22/2023 | Restricted Stock Vesting Compensation | 20.85K | — |
| Total | 20.85K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20.85K
Market value
$672.2K
9/11/2025
Total
Units
20.85K
Value
$672.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/11/2025 | 20.85K | $672.2K | NASDAQ | Planned |
| Total | 20.85K | $672.2K | ||